CBLN1 and central nervous system cancer: As briefly stated in Fig. 3F, the FASN inhibitor CER markedly suppressed the differentiation characteristics of glioma cells by reducing EMT- and stemness-related mesenchymal marker levels, thus attenuating the cells’ colony-forming capacity, and migrative and invasive ability.